Incidence of bleeding in patients on different anticoagulants and antiplatelet therapies undergoing thoracentesis.
Lamia AljundiAbdelkader ChaarPeter BosharaAryan ShiariGeorge GennaouiZaid NooriCristine GirardSuzan SzpunarRene Franco-ElizondoPublished in: BMJ open respiratory research (2021)
Our study suggests that performing thoracentesis without correction of underlying coagulopathy may be safe. This may prevent consequences of holding essential medications and reduce the amount of blood products administered to patients in need of thoracentesis.